If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Ichiro Ieiri is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Pharmacokinetics Medicine & Life Sciences
Pharmacogenetics Medicine & Life Sciences
Genetic Polymorphisms Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
Genes Medicine & Life Sciences
Phenytoin Medicine & Life Sciences
Healthy Volunteers Medicine & Life Sciences
Population Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1988 2019

6 Citations (Scopus)

Clinical Pharmacokinetics of Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer

Hirota, T., Muraki, S. & Ieiri, I., Apr 4 2019, In : Clinical Pharmacokinetics. 58, 4, p. 403-420 18 p.

Research output: Contribution to journalReview article

Non-Small Cell Lung Carcinoma
Pharmaceutical Preparations
Cytochrome P-450 Enzyme System
Cytochrome P-450 CYP3A
4 Citations (Scopus)

Effect of OATP1B1 genotypes on plasma concentrations of endogenous OATP1B1 substrates and drugs, and their association in healthy volunteers

Mori, D., Kashihara, Y., Yoshikado, T., Kimura, M., Hirota, T., Matsuki, S., Maeda, K., Irie, S., Ieiri, I., Sugiyama, Y. & Kusuhara, H., Feb 1 2019, In : Drug metabolism and pharmacokinetics. 34, 1, p. 78-86 9 p.

Research output: Contribution to journalArticle

Healthy Volunteers
Pharmaceutical Preparations

Effects of magnesium oxide on pharmacokinetics of L-dopa/carbidopa and assessment of pharmacodynamic changes by a model-based simulation

Kashihara, Y., Terao, Y., Yoda, K., Hirota, T., Kubota, T., Kimura, M., Matsuki, S., Hirakawa, M., Irie, S. & Ieiri, I., Mar 6 2019, In : European Journal of Clinical Pharmacology. 75, 3, p. 351-361 11 p.

Research output: Contribution to journalArticle

Magnesium Oxide
3 Citations (Scopus)

Efficacy of DPP-4 inhibitors, GLP-1 analogues, and SGLT2 inhibitors as add-ons to metformin monotherapy in T2DM patients: a model-based meta-analysis

Inoue, H., Tamaki, Y., Kashihara, Y., Muraki, S., Kakara, M., Hirota, T. & Ieiri, I., Feb 2019, In : British journal of clinical pharmacology. 85, 2, p. 393-402 10 p.

Research output: Contribution to journalArticle

Glucagon-Like Peptide 1
Hypoglycemic Agents
Type 2 Diabetes Mellitus

Elucidation of N1-methyladenosine as a potential surrogate biomarker for drug interaction studies involving renal organic cation transporters

Miyake, T., Mizuno, T., Takehara, I., Mochizuki, T., Kimura, M., Matsuki, S., Irie, S., Watanabe, N., Kato, Y., Ieiri, I., Maeda, K., Ando, O. & Kusuhara, H., Jan 1 2019, In : Drug Metabolism and Disposition. 47, 11, p. 1270-1280 11 p.

Research output: Contribution to journalArticle

Drug Interactions
Pharmaceutical Preparations